Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention

2005-04-01

The Annals of Pharmacotherapy , Volume 39 - Issue 4 p. 610- 616

Additional Metadata
Keywords	Angioplasty, Coronary disease, Cost-benefit analysis, Hypercholesterolemia
Persistent URL	doi.org/10.1345/aph.1E367, hdl.handle.net/1765/67596
Journal	The Annals of Pharmacotherapy
Organisation	Department of Cardiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Delea, T.E, Jacobson, T.A, Serruys, P.W.J.C, Edelsberg, J.S, & Oster, G. (2005). Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention. The Annals of Pharmacotherapy, 39(4), 610–616. doi:10.1345/aph.1E367

Publication